PW03-018 – Efficacy of Anakinra in recurrent pericarditis

PW03-018 – Efficacy of Anakinra in recurrent pericarditis

Methods Fifteen patients (12 pediatrics and 3 adults; M:F=11:4) affected by idiopathic recurrent pericarditis and followed by 6 different national referral centers were enrolled in the study. The mean age was 22 years (range 9-60 yrs); mean age at onset was 16 years (5-49 yrs), mean age at the beginning of treatment was 19 years (6-56 yrs). All patients received an initial dosage of 1-2 mg/Kg/d...

[Efficacy of anakinra as a treatment for recurrent pericarditis].

Recurrent pericarditis: can anakinra offer a promising therapy in adults with refractory symptoms?

We read with great pleasure the work by Imazio, which is, as usual, another of his excellent contributions to pericardial disease research. Imazio discussed the treatment of recurrent pericarditis and emphasized the importance of colchicine in addition to the standard treatment modalities. This is backed up by randomized controlled evidence from CORP-1 and CORP-2 trials, which constitute the pi...

Recurrent Pericarditis

It occurs in 15% to 32% of cases and the cause of the recurrence is usually unknown, although in some cases it may be traced to viral infection or may be a consequence of coronary artery bypass grafting1. The optimal method for prevention has not been fully established; accepted modalities include nonsteroidal anti-inflammatory drugs, corticosteroids, colchicines, immunosuppressive agents, and ...

Therapy of recurrent pericarditis.

e read with interest the paper by Raatikka et al. (1) that gives us useful piece of information regarding pericarditis in children. he data are relevant, particularly regarding the good long-term utcome, with no instance of constriction, in agreement with our xperience in adults. We would like to comment on some tatements regarding therapy. The authors in fact conclude that orticosteroids, meth...